219 related articles for article (PubMed ID: 25961597)
1. A Microfluidic Platform for Evaluating Neutrophil Chemotaxis Induced by Sputum from COPD Patients.
Wu J; Hillier C; Komenda P; Lobato de Faria R; Levin D; Zhang M; Lin F
PLoS One; 2015; 10(5):e0126523. PubMed ID: 25961597
[TBL] [Abstract][Full Text] [Related]
2. Impaired neutrophil chemotaxis in chronic obstructive pulmonary disease.
Yoshikawa T; Dent G; Ward J; Angco G; Nong G; Nomura N; Hirata K; Djukanovic R
Am J Respir Crit Care Med; 2007 Mar; 175(5):473-9. PubMed ID: 17110644
[TBL] [Abstract][Full Text] [Related]
3. The effect of induced sputum and bronchoalveolar lavage fluid from patients with chronic obstructive pulmonary disease on neutrophil migration in vitro.
Babusyte A; Jeroch J; Stakauskas R; Stravinskaite K; Malakauskas K; Sakalauskas R
Medicina (Kaunas); 2010; 46(5):315-22. PubMed ID: 20679746
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil chemotactic activity of sputum from patients with COPD: role of interleukin 8 and leukotriene B4.
Beeh KM; Kornmann O; Buhl R; Culpitt SV; Giembycz MA; Barnes PJ
Chest; 2003 Apr; 123(4):1240-7. PubMed ID: 12684317
[TBL] [Abstract][Full Text] [Related]
5. Leukotriene B4 contributes to exhaled breath condensate and sputum neutrophil chemotaxis in COPD.
Corhay JL; Henket M; Nguyen D; Duysinx B; Sele J; Louis R
Chest; 2009 Oct; 136(4):1047-1054. PubMed ID: 19429719
[TBL] [Abstract][Full Text] [Related]
6. Effect of cilomilast (Ariflo) on TNF-alpha, IL-8, and GM-CSF release by airway cells of patients with COPD.
Profita M; Chiappara G; Mirabella F; Di Giorgi R; Chimenti L; Costanzo G; Riccobono L; Bellia V; Bousquet J; Vignola AM
Thorax; 2003 Jul; 58(7):573-9. PubMed ID: 12832668
[TBL] [Abstract][Full Text] [Related]
7. Sputum chemotactic activity in chronic obstructive pulmonary disease: effect of alpha(1)-antitrypsin deficiency and the role of leukotriene B(4) and interleukin 8.
Woolhouse IS; Bayley DL; Stockley RA
Thorax; 2002 Aug; 57(8):709-14. PubMed ID: 12149532
[TBL] [Abstract][Full Text] [Related]
8. Bronchoalveolar Lavage Fluid from Chronic Obstructive Pulmonary Disease Patients Increases Neutrophil Chemotaxis Measured by a Microfluidic Platform.
Ren J; Chen W; Zhong Z; Wang N; Chen X; Yang H; Li J; Tang P; Fan Y; Lin F; Bai C; Wu J
Micromachines (Basel); 2023 Sep; 14(9):. PubMed ID: 37763903
[TBL] [Abstract][Full Text] [Related]
9. Effect of theophylline on induced sputum inflammatory indices and neutrophil chemotaxis in chronic obstructive pulmonary disease.
Culpitt SV; de Matos C; Russell RE; Donnelly LE; Rogers DF; Barnes PJ
Am J Respir Crit Care Med; 2002 May; 165(10):1371-6. PubMed ID: 12016098
[TBL] [Abstract][Full Text] [Related]
10. An All-on-chip Method for Rapid Neutrophil Chemotaxis Analysis Directly from a Drop of Blood.
Yang K; Wu J; Zhu L; Liu Y; Zhang M; Lin F
J Vis Exp; 2017 Jun; (124):. PubMed ID: 28671651
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil activation in severe, early-onset COPD patients versus healthy non-smoker subjects in vitro: effects of antioxidant therapy.
Milara J; Juan G; Peiró T; Serrano A; Cortijo J
Respiration; 2012; 83(2):147-58. PubMed ID: 22094549
[TBL] [Abstract][Full Text] [Related]
12. Sputum from chronic obstructive pulmonary disease patients inhibits T cell migration in a microfluidic device.
Ren X; Wu J; Levin D; Santos S; de Faria RL; Zhang M; Lin F
Ann N Y Acad Sci; 2019 Jun; 1445(1):52-61. PubMed ID: 30891781
[TBL] [Abstract][Full Text] [Related]
13. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation].
Xin XF; Zhao M; Li ZL; Song Y; Shi Y
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998
[TBL] [Abstract][Full Text] [Related]
14. Increased of exhaled breath condensate neutrophil chemotaxis in acute exacerbation of COPD.
Corhay JL; Moermans C; Henket M; Nguyen Dang D; Duysinx B; Louis R
Respir Res; 2014 Sep; 15(1):115. PubMed ID: 25260953
[TBL] [Abstract][Full Text] [Related]
15. CCSP counterbalances airway epithelial-driven neutrophilic chemotaxis.
Knabe L; Petit A; Vernisse C; Charriot J; Pugnière M; Henriquet C; Sasorith S; Molinari N; Chanez P; Berthet JP; Suehs C; Vachier I; Ahmed E; Bourdin A
Eur Respir J; 2019 Jul; 54(1):. PubMed ID: 31023848
[TBL] [Abstract][Full Text] [Related]
16. SiMA: A simplified migration assay for analyzing neutrophil migration.
Weckmann M; Becker T; Nissen G; Pech M; Kopp MV
Cytometry A; 2017 Jul; 91(7):675-685. PubMed ID: 28544679
[TBL] [Abstract][Full Text] [Related]
17. Platinum-based, leukocyte-depleting chemotherapy does not alter induced sputum markers of neutrophilic inflammation in COPD patients with unresectable non-small cell lung cancer.
Beeh KM; Beier J; Ernst M; Kornmann O; Buhl R
Respiration; 2003; 70(2):166-71. PubMed ID: 12740514
[TBL] [Abstract][Full Text] [Related]
18. Increased neutrophil migration in smokers with or without chronic obstructive pulmonary disease.
Blidberg K; Palmberg L; Dahlén B; Lantz AS; Larsson K
Respirology; 2012 Jul; 17(5):854-60. PubMed ID: 22509802
[TBL] [Abstract][Full Text] [Related]
19. Increased 25-hydroxycholesterol concentrations in the lungs of patients with chronic obstructive pulmonary disease.
Sugiura H; Koarai A; Ichikawa T; Minakata Y; Matsunaga K; Hirano T; Akamatsu K; Yanagisawa S; Furusawa M; Uno Y; Yamasaki M; Satomi Y; Ichinose M
Respirology; 2012 Apr; 17(3):533-40. PubMed ID: 22295989
[TBL] [Abstract][Full Text] [Related]
20. Behavioral and structural differences in migrating peripheral neutrophils from patients with chronic obstructive pulmonary disease.
Sapey E; Stockley JA; Greenwood H; Ahmad A; Bayley D; Lord JM; Insall RH; Stockley RA
Am J Respir Crit Care Med; 2011 May; 183(9):1176-86. PubMed ID: 21257786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
